NOT-CA-24-110: Notice of Participation of National Cancer Institute in PA-25-080: NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

Notice of Participation of National Cancer Institute in PA-25-080: NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

Notice Number:

NOT-CA-24-110

Key Dates

Release Date:

October 10, 2024

Related Announcements

October 2, 2024 - NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed). See NOFO PA-25-080.

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform potential applicants that effective October 10, 2024, the National Cancer Institute (NCI) will participate in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)" issued by the National Institutes of Health.

To reflect the participation of NCI, text has been added to Part 1. Overview Information of PA-25-080 as follows:

Part 1. Overview Information

Components of Participating Organizations

National Cancer Institute (NCI)

Assistance Listing Number(s)

93.393, 93.394, 93.395, 93.396, 93.399

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Scott Chen, Ph.D.
Chief, Program Coordination and Referral Branch (PCRB)
Division of Extramural Activities
National Cancer Institute
Email: ncirefof@dea.nci.nih.gov